Literature DB >> 175815

The lack of association of theta status and murine leukaemia virus content in the AKR.

R D Barnes, K Brown.   

Abstract

Two AKR sublines appear atypical in possessing theta C3H. One of these two sublines - AKR/FuA - is notably resistant to lymphomata and is also characterized by reduced levels of the group specific murine leukaemia viral (MuLV) antigen. This suggested a possible association between theta status tumour susceptibility and viral content. Results here show no reduction in viral antigen titres in the other theta C3H tumour susceptible subline AKR/Cum, thus eliminating the possible association of theta status with the extent of MuLV replication.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 175815      PMCID: PMC2025014          DOI: 10.1038/bjc.1975.278

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  4 in total

1.  Variations among sublines of inbred AKR mice.

Authors:  R T Acton; E P Blankenhorn; T C Douglas; R D Owen; J Hilgers; H A Hoffman; E A Boyse
Journal:  Nat New Biol       Date:  1973-09-05

2.  Detection of avian and mammalian oncogenic RNA viruses (oncornaviruses) by immunofluorescence.

Authors:  J Hilgers; R C Nowinski; G Geering; W Hardy
Journal:  Cancer Res       Date:  1972-01       Impact factor: 12.701

3.  Suppression of lymphoma development in tetraparental AKR mouse chimaeras derived from ovum fusion.

Authors:  R D Barnes; M Tuffrey; C E Ford
Journal:  Nat New Biol       Date:  1973-08-29

4.  Characterization of a rapidly growing AKR lymphoblastic cell line maintaining Gross antigens and viral replication.

Authors:  W A Woods; N A Wivel; J G Massicot; M A Chirigos
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

  4 in total
  2 in total

1.  Lymphoma susceptibility of the thetaC3H AKR/CUM.

Authors:  M A Tuffrey; P Crewe; L Dawson
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

2.  Anticancer activity and chemoprevention of xenobiotic organosulfurs in preclinical model systems.

Authors:  Robert E Click
Journal:  Oncol Discov       Date:  2013
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.